Status:
RECRUITING
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Upper Gastrointestinal Bleeding
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the management of patients with acute upper non-variceal upper gastrointestinal bleeding, further bleeding is the most important adverse factor predictive of mortality. In the United Kingdom Audit ...
Detailed Description
The current standard of care in patients with refractory bleeding from their peptic ulcers and other non-variceal causes has not been defined. An International Consensus Group recommends a surgical co...
Eligibility Criteria
Inclusion
- 1\. Patients presented with overt signs of acute upper gastrointestinal bleeding (hematemesis, melena and/or hypotension) 2. documented bleeding lesion at endoscopy (ulcer, dieulafoy's lesion and others), further bleeds (persistent or recurrent) after endoscopic hemostasis (thermal or hemoclips) as defined by an International Consensus Group
Exclusion
- without a full informed consent from the patient or his next of kin
- Age \<18 years
- Pregnant
- Lactating women
- patients with known allergy to intravenous contrast
Key Trial Info
Start Date :
November 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 24 2025
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT04902248
Start Date
November 27 2021
End Date
December 24 2025
Last Update
June 20 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing friendship Hospital
Beijing, Beijing Municipality, China
2
the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
3
Huaxi Hospital of Sichuan University
Chengdu, Sichuan, China
4
Endoscopy Centre, Prince of Wales Hospital
Hong Kong, N.T., Hong Kong